(3aR, 4S, 6R, 6aS) -6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol CAS 155899-66-4

Khoom Piav Qhia:

Khoom Lub Npe: (3aR, 4S, 6R, 6aS) -6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol CAS TSIS TAU: 155899-66-4

Lub ntsiab lus:

6-AMinotetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-ol;

Ticagrelor Muaj feem xyuam 1 ((3aR, 4S, 6R, 6aS) -6-Aminotetrahydro-2,2-Dimethyl-4H-Cyclopenta-1.3-dioxol-4-ol);

Tshuaj& Lub Cev Muaj Zog:

Tshwm sim: Khoom

Kev Ntsuas: ≥99.00%

Ceev: 1.17

Kub Point: 288 ℃

Melting Point: 85-88 ℃

Flash Point: 128 ℃

Vapor Siab: 0.0 ± 1.3 mmHg ntawm 25 ℃

Index ntawm Refraction: 1.498

Cov Ntaub Ntawv Kev Nyab Xeeb:

Lo Lus Teeb: Ceeb Toom

Cov lus ceeb toom ua ntej: P261-P305+P351+P338

Cov Lus Qhia Teeb Meem: H302-H315-H319-H335

(3aR, 4S, 6R, 6aS) -6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol tau siv los npaj ua ntej AZD6140 raws li qhov ncauj hais kom rov ua tau zoo P2Y12 receptor antagonist rau kev tiv thaiv kev mob ntshav khov .

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.

Cim npe nrov: (3ar, 4s, 6r, 6as) -6-aminotetrahydro-2,2-dimethyl-4h-cyclopenta-1,3-dioxol-4-ol cas 155899-66-4, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

• Tug: Candesartan Cilexetil CAS 145040-37-5
• Tom ntej: 3ALPHA-HYDROXY-7-OXO-5BETA-CHOLANIC ACID CAS 4651-67-6